Sequestered naltrexone in sustained release morphine or oxycodone – a way to inhibit illicit use?

作者: Robert B Raffa , Robert Taylor , Joseph V Pergolizzi

DOI: 10.1517/14740338.2013.841136

关键词:

摘要: Introduction: Under the growing concern about prescription opioid misuse, abuse, addiction, tampering and diversion, stakeholders (e.g, governments, pharmaceutical companies health care providers) are developing formulations that they hope less attractive to those seeking misuse or abuse pain medications. However, these products must maintain their therapeutic effectiveness safety. Many abusers tamper with in an effort convert active ingredient into a form suitable for alternative more abuse-desirable routes of administration, such as snorting, inhaling injecting. Areas covered: A tamper-deterrent strategy is embed antagonists agonist formulation. Upon tampering, antagonist released binds receptors sufficient amount impede access agonist. This approach intended reduce subjective rewarding effects euphoria which prominent following swallowing dosage w...

参考文章(46)
Harald Breivik, Beverly Collett, Vittorio Ventafridda, Rob Cohen, Derek Gallacher, Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. European Journal of Pain. ,vol. 10, pp. 287- 333 ,(2006) , 10.1016/J.EJPAIN.2005.06.009
L A Rounds, R L Brown, Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wisconsin medical journal. ,vol. 94, pp. 135- 140 ,(1995)
Laxmaiah Manchikanti, Paul J. Christo, Xiulu Ruan, Arthur E. Jordan, Hans Hansen, Michael Bottros, Daneshvari R. Solanki, James Colson, Urine drug testing in chronic pain. Pain Physician. ,vol. 14, pp. 123- 143 ,(2011) , 10.36076/PPJ.2011/14/123
R C Nelson, C Baum, J P Hsu, The impact of the addition of naloxone on the use and abuse of pentazocine. Public Health Reports. ,vol. 102, pp. 426- 429 ,(1987)
Joseph Stauffer, Beatrice Setnik, Marta Sokolowska, Myroslava Romach, Franklin Johnson, Edward Sellers, Subjective Effects and Safety of Whole and Tampered Morphine Sulfate and Naltrexone Hydrochloride (ALO-01) Extended-Release Capsules versus Morphine Solution and Placebo in Experienced Non-Dependent Opioid Users Clinical Drug Investigation. ,vol. 29, pp. 777- 790 ,(2009) , 10.2165/11530800-000000000-00000
Vincent C. Badalamenti, PharmD, Jill W. Buckley, PharmD, Eric T. Smith, PharmD, Safety of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules: Review of postmarketing adverse events during the first year Journal of opioid management. ,vol. 8, pp. 115- 125 ,(2012) , 10.5055/JOM.2012.0104
Pampati, Manchikanti L, Fellows B, Ailinani H, Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective Pain Physician. ,vol. 13, pp. 401- 435 ,(2010) , 10.36076/PPJ.2010/13/401
Ramsin Benyamin, Rajive Adlaka, Samir Patel, Andrea M Trescot, Hans Hansen, Scott E Glaser, Standiford Helm, Laxmaiah Manchikanti, Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician. ,vol. 11, ,(2008) , 10.36076/PPJ.2008/11/S5
Leonard J. Paulozzi, Rose A. Rudd, Karin A. Mack, Christopher M. Jones, Vital Signs: Overdoses of Prescription Opioid Pain Relievers - United States, 1999-2008 Morbidity and Mortality Weekly. ,vol. 60, pp. 1487- ,(2011)